Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 389 clinical trials
S-1 Cisplatin and Radiation Therapy in Treating Patients With Stage IIA Stage III or Stage IVA Esophageal Cancer That Can Be Removed by Surgery

phase II trial is studying how well giving S-1 and cisplatin together with radiation therapy works in treating patients with stage IIA, stage III, or stage IVA esophageal cancer that can be

x-rays
potassium
cancer
combination chemotherapy
tumor cells
  • 3 views
  • 07 Nov, 2020
  • 1 location
Phase / Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

CpG7909 in patients with advanced or recurrent esophageal cancer.

peptide vaccine
ct scan
platelet count
recurrent esophageal cancer
cancer
  • 5 views
  • 07 Nov, 2020
  • 1 location
Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus

therapy will kill cancer cells in patients with squamous cell carcinoma of the esophagus.

esophageal carcinoma
carcinoma
squamous cell carcinoma of esophagus
fluorouracil
cancer
  • 7 views
  • 07 Nov, 2020
  • 2 locations
Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper Gastrointestinal Cancer Surgery

This study aims to examine whether providing tube feeding with a formula enriched with omega-3 fats is better than traditional standard tube feeding in terms of preserving nutritional status, improving immune function and reducing medical complications following major upper Gut cancer surgery.

cancer
gastrointestinal cancer
esophageal cancer
  • 29 views
  • 07 Nov, 2020
  • 1 location
Trial of Docetaxel Cisplatin Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

and 5-fluorouracil (DCF) in unresectable advanced esophageal cancer. The usefulness of the this regimen is evaluated by RECIST, time to progression and median survival time.

carcinoma
ct scan
platelet count
recurrent esophageal cancer
cancer
  • 9 views
  • 07 Nov, 2020
  • 1 location
CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer

The study is to assess the safety and efficacy of the immunotherapies using anti-MUC1 CAR T cells and /or PD-1 knockout engineered T cells in the treatment of patients with advanced esophageal

  • 4 views
  • 22 Jan, 2021
  • 1 location
Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer

overall survival time (OS) in patients with Stage IIB or III squamous cell esophageal carcinoma.

  • 26 views
  • 08 Nov, 2020
  • 1 location
  • 20 views
  • 22 Jan, 2021
  • 1 location
Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer

In this prospective single center study, up to 25 patients with Barrett's esophagus with LGD or no dysplasia (Group 1), 25 patients with HGD/IMCA (Group 2), 25 patients with esophageal

esophageal carcinoma
carcinoma
dysplasia
cancer
endoscopic biopsy
  • 43 views
  • 07 Nov, 2020
  • 1 location
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer

chemotherapy. However, the efficacy and safety of immunotherapy therapy in surgery-based multidisciplinary treatment of local advanced esophageal cancer still need a lot of clinical studies to further confirm

  • 0 views
  • 25 Jan, 2021
  • 1 location